Global Information, Inc. would like to present a new market research report, "NANO-ENABLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY - A GLOBAL TECHNOLOGY, INDUSTRY AND MARKET ANALYSIS" by Innovative Research and Products (iRAP).
In 2009, the total market for nano-enabled packaging for pharmaceuticals was worth $3.8 billion. According to iRAP, Inc. researchers, the pharmaceutical nano-enabled packaging market is projected to reach $8.1 billion, rising at a compound annual growth rate (CAGR) of 16.5% between 2009 and 2014. Packaging in the pharmaceutical industry has undergone major changes in the recent decade. Contemporary pharmaceutical packaging design ensures the crucial components of the safety, convenience and compliance of drug use, such as stability and shelf life of both the drug and drug delivery systems. The largest consumers of pharmaceutical packaging will be the U.S. and Europe. Meanwhile, China will exhibit the strongest growth opportunities for pharmaceutical nano-enabled packaging.
Key findings of iRAPs study include:
- Among all pharmaceutical packaging products, global demand for pre-fillable inhalers and pre-fillable syringes will generate the fastest growth opportunities.
- Global demand for pharmaceutical blister packaging will display positive growth based on unit does adaptability, clinical trials, compliance, over-the-counter and institutional drugs
- Child resistant, senior friendly, and dispensing closures; high visibility labels; anti-counterfeit and tamper-evident accessories will lead global market growth for pharmaceutical closures and accessories.
GLOBAL MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014